Tamiflu Resistance Detected In Vietnamese Bird Flu Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Oseltamivir manufacturer Roche asserts that it maintains several monitoring mechanisms to evaluate efficacy of the antiviral.
You may also be interested in...
Roche Will Sell Tamiflu Under Tiered Pricing System For Pandemic Use
The firm names Shanghai Pharmaceutical Group as the first sub-licensee of the antiviral oseltamivir.
“Pharmaco-Metabonomics” Holds Promise for Personalized Drug Therapies, Researchers Say
The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.
NCI-Funded Researchers Are Patenting At Surprisingly High Rate, Report Says
More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.